Mumps Virus Explained: Parotitis to Outbreaks

Mumps sounds almost quaint: a swollen jaw, a few days of misery, a childhood rite of passage for people born before vaccines. Yet the mumps virus can inflame the testes, the membranes around the brain, and, in rare cases, the inner ear, and it has returned in places with high vaccination coverage. Before the US program began in 1967, about 186,000 cases were reported each year, and routine two-dose vaccination cut that by 99%. [1] This article explains how the virus works, why immunity fades, and what outbreaks reveal.

Educational content, not medical advice. Talk to your doctor before changing any medication, treatment, or routine. Information here reflects published research and public health sources, but every person's situation differs.

What kind of virus is mumps?

Mumps virus belongs to the family Paramyxoviridae, which also contains measles virus, respiratory syncytial virus (RSV), the parainfluenza viruses, and the Nipah and Hendra viruses. For the measles side of the family, see the measles virus explainer.

Like its relatives, mumps is an enveloped, single-stranded, negative-sense RNA virus. "Enveloped" means it wears an outer fatty membrane taken from the host cell. "Negative-sense" means the genome is the mirror image of a messenger RNA, so the virus must carry its own copying enzyme into the cell and use it before anything else can happen. The genome is roughly 15,000 nucleotides long.

Two surface proteins do most of the work. The hemagglutinin-neuraminidase (HN) protein attaches the virus to sugars on the cell surface and also snips those sugars to free new virus particles at the end of the cycle. The fusion (F) protein then merges the viral envelope with the cell membrane. These two proteins are also the main targets of neutralizing antibodies, so they shape both the disease and the vaccine. For the general steps any virus follows from entry to release, see how viruses work from infection to replication.

One serotype, several genotypes

Mumps has a single serotype, meaning antibodies made against one strain recognize the others well enough to be useful. Strains are still sorted into genotypes labeled by letters. A 2008 study found that antibody induced by the Jeryl Lynn vaccine strain neutralized a genotype G virus from a large outbreak at every time point tested, although antibody levels against the outbreak virus were about half those against the vaccine strain. [2] That finding became important in the debate over why outbreaks happen, and the answer turned out to be less about the virus changing and more about immunity fading, as described below.

How the virus finds its target

The receptor

Mumps HN prefers a particular sugar structure: a trisaccharide containing sialic acid linked in the alpha-2,3 position on unbranched chains. [3] Researchers solved crystal structures showing how an aromatic amino acid beyond the sialic-acid pocket helps hold the third sugar in place. [3] Later work identified additional glycan motifs that HN can bind. [4]

Think of the cell surface as a coat covered in sugar tassels. Mumps HN is a hand that grips one particular tassel shape. Many cells carry that shape, which helps explain why the virus can reach several organs.

Why the parotid glands

The hallmark of mumps is swelling of the parotid glands, the large salivary glands in front of and below each ear. These glands drain into the mouth, so infection there fills saliva with virus. That is an effective way to spread through coughing, talking, and shared cups. The review by Rubin and colleagues also notes that mumps is highly neurotropic, meaning it readily infects the nervous system, with laboratory evidence of central nervous system infection in about half of cases even though symptomatic disease is less common. [5]

The infection timeline

The CDC gives the average incubation period as 16 to 18 days, with a range of 12 to 25 days. [6] A person is considered contagious from 2 days before to 5 days after the onset of parotid swelling. [6] Virus has been isolated from saliva as early as 7 days before and up to 9 days after onset, and from urine and semen for up to 14 days. [6]

Stage	Typical timing	What happens
Exposure	Day 0	Virus enters through the respiratory tract or mouth
Incubation	Days 12 to 25 (average 16 to 18)	No symptoms; virus spreads through the body
Pre-symptomatic contagion	About 2 days before swelling	Person can already pass the virus on
Prodrome	1 to 2 days (typical)	Low fever, headache, tiredness, loss of appetite
Parotitis	Swelling peaks within 1 to 3 days	Swelling subsides over the following week
End of the standard contagious period	5 days after swelling begins	Isolation guidance ends

The pre-symptomatic window is the central problem for control. A person in a dormitory can spread mumps for two days before anyone suspects it, which is long enough to reach a whole floor.

What mumps looks like

The classic picture

The CDC describes mumps as a contagious viral disease of the salivary glands, with a swollen, tender jaw and puffy cheeks, usually under one or both ears. Early symptoms can include fever, tiredness, loss of appetite, and headache. Most people recover completely within about two weeks. [7] The swelling often starts on one side and may spread to the other. Chewing, swallowing, and acidic foods can be painful because they trigger saliva flow in an inflamed gland.

Mild and silent infections

Not every infection looks like the textbook. Vaccinated people who catch mumps often have milder illness, and some people have no obvious swelling at all. The CDC states that most cases and outbreaks now occur among fully vaccinated people in close-contact or congregate settings. [6] This makes recognition harder, because many clinicians now see few cases and a milder presentation may not trigger testing.

Complications: when mumps goes beyond the cheeks

Serious complications are uncommon, but they explain why public health agencies take mumps seriously. The table shows figures from surveillance and outbreak studies. These are rates in specific populations and periods, not individual risk.

Complication	Figure	Source
Orchitis (testicular inflammation)	4.4% of notified cases in England and Wales, 2002 to 2006 (6.1% in enhanced surveillance)	Yung et al., 2011 [8]
Orchitis in a 2009 to 2010 outbreak	120 cases, 7% of males aged 12 and older	Barskey et al., 2012 [9]
Meningitis	0.35% of notified cases (0.3% in enhanced surveillance)	Yung et al., 2011 [8]
Pancreatitis	0.33% of notified cases (0.25% in enhanced surveillance)	Yung et al., 2011 [8]
Meningoencephalitis in a large outbreak	0.5%	Zamir et al., 2015 [10]
Testicular atrophy after orchitis	47 of 132 men in a Minnesota series, 1935 to 1974	Mayo Clinic Proceedings, 1977 [11]

Rates vary with the age of the people affected, with how cases are counted, and with vaccination status, which is why the figures differ between studies.

Orchitis

In males past puberty, mumps can inflame one or both testes. It brings pain, swelling, fever, and nausea. In the Minnesota series, 47 of 132 men with orchitis later had an atrophic (shrunken) testis. [11] Orchitis in most cases affects one side, which is why infertility is not the usual outcome, though specialists continue to study effects on semen quality. This article does not give individual medical advice; anyone with sudden scrotal pain needs prompt medical evaluation.

Oophoritis, meningitis, and the brain

Inflammation of the ovaries (oophoritis) can occur in females after puberty and causes lower abdominal pain. The nervous system is a more common target. Meningitis, which is inflammation of the membranes around the brain and spinal cord, appeared in about 0.35% of notified cases in England and Wales. [8] The CDC notes that brain inflammation is the most serious complication. [7] Most people with mumps meningitis recover without lasting problems, though outcomes vary.

Hearing loss

Mumps is a recognized cause of sensorineural hearing loss, damage to the inner ear or auditory nerve. It is usually on one side, which can delay recognition, and once present it is permanent. Because case numbers are small, reliable rates are hard to pin down, and this article does not give a figure.

Diagnosis and care

Clinicians often suspect mumps from the swelling and an exposure history. Laboratory confirmation, which public health departments rely on, usually uses reverse transcription polymerase chain reaction (RT-PCR) on a swab of the cheek or throat, which finds the virus's genetic material. Blood tests for IgM antibodies can be unreliable in vaccinated people, whose immune memory may produce a rapid IgG response without a clear IgM peak.

Care is supportive: rest, fluids, and pain or fever relief as advised by a clinician. The CDC advises people with mumps to contact a doctor and to limit contact with others for up to five days after swelling begins. [7] Anyone with severe headache, stiff neck, abdominal pain, or testicular pain should seek medical care.

The MMR vaccine

The measles-mumps-rubella (MMR) vaccine contains live, weakened viruses. Its mumps component is the Jeryl Lynn strain, named after the child from whom it was first isolated in the 1960s. The CDC recommends two doses of MMR for children, and the Advisory Committee on Immunization Practices recommends a third dose for people at increased risk during an outbreak. [6] For an overview of how this kind of vaccine trains the immune system, see how vaccines actually work.

How well does it work?

Effectiveness estimates differ by study, outbreak, and how cases and vaccination status were verified. The ranges below come from published outbreak investigations.

Study	Setting	One-dose effectiveness	Two-dose effectiveness
Cohen et al., 2007	England, 2004 to 2005 outbreak	88% (95% CI 83% to 91%)	95% (95% CI 93% to 96%) [12]
Marin et al., 2008	US outbreak	Similar to earlier one-dose estimates	76% to 88% [13]
Deeks et al., 2011	Canada	49.2% to 81.6%	66.3% to 88.0% [14]

Two doses are clearly better than one, but two doses are not a guarantee. Part of the difference between studies comes from the way effectiveness is measured. In an outbreak where exposure is intense, even a good vaccine will show some failures.

Why vaccinated populations still have outbreaks

For years, epidemiologists argued about two explanations: the virus changed, or immunity faded. The genotype data above argue against the first. The second has strong support.

Waning immunity

Lewnard and Grad, writing in Science Translational Medicine in 2018, pooled data from six vaccine-effectiveness studies and estimated that vaccine-derived protection wanes on average 27 years after vaccination (95% confidence interval 16 to 51 years). [15] Their transmission model supported waning immunity as the central driver of mumps re-emergence. [15] After accounting for waning, they found no evidence that emerging genotypes changed vaccine effectiveness over time. [15] Outbreaks among young adults from 2006 onward, and among adolescents in the late 1980s and early 1990s, matched peaks in susceptibility that the model predicted from lost vaccine protection. [15]

A useful analogy is a library card that expires at different rates for different people. Most people still hold a valid card years later, but the share who have lost theirs creeps up over time. A large, mostly protected group can still contain enough lapsed members to carry an outbreak, as long as they spend time close together.

Close contact

Mumps does not need many unprotected people if they are packed together. The 2009 to 2010 outbreak among Orthodox Jewish communities had 3,502 cases between June 28, 2009 and June 27, 2010, in New York City, two upstate New York counties, and one New Jersey county. [9] Among 13- to 17-year-olds with documented vaccination status, 89% had received two doses of a mumps-containing vaccine. [9] Transmission centered on boys' schools, where students interact face to face for many hours a day, and the authors concluded that intense exposure overcame vaccine-induced protection while high two-dose coverage reduced disease severity and limited spread to settings with less intense exposure. [9]

Outbreaks at a glance

Outbreak	What happened	Key numbers
United States, 2006	Largest US outbreak in two decades, centered in the Midwest	6,584 cases; 76% between March and May; 83% of a subgroup aged 18 to 24 were attending college; 63% of cases with known status had two doses [16]
New York and New Jersey, 2009 to 2010	Spread through boys' schools	3,502 cases; 97% in Orthodox Jewish persons [9]
University of Iowa, 2015 to 2016	Outbreak among vaccinated students	259 cases among 20,496 students; 98.1% had at least two doses [17]

The 2006 outbreak mattered because it happened when national two-dose coverage among adolescents was 87%, the highest in US history. [16] The authors saw it as evidence of two-dose vaccine failure among college-age adults who probably received their second dose as schoolchildren. [16]

The third dose

The University of Iowa outbreak gave researchers a rare chance to measure the effect of an extra dose. Among 20,496 students, 259 were diagnosed with mumps, and 4,783 received a third MMR dose during the outbreak. [17] The attack rate was 6.7 per 1,000 for students with three doses and 14.5 per 1,000 for those with two. [17] Students whose second dose was 13 or more years earlier had more than nine times the risk of mumps. [17] At 28 days after vaccination, a third dose was associated with a 78.1% lower risk than a second dose (adjusted hazard ratio 0.22). [17]

That result supports targeted third doses during outbreaks. It does not by itself show that routine boosters would prevent outbreaks. Lewnard and Grad suggested a third dose at age 18, or booster doses throughout adulthood, as strategies that should be tested in clinical trials. [15] That is a research proposal, not current policy.

A note on herd immunity

Herd immunity is the point at which enough people are immune that each case infects fewer than one other person on average. The textbook formula is 1 minus 1 divided by R0, where R0 (the basic reproduction number) is the average number of people infected by one case in a fully susceptible population. If R0 were 5, the threshold would be 80%. If R0 were 7, it would be about 86%.

The formula assumes immunity is uniform and permanent. Mumps shows why that is a simplification. Immunity wanes, and contact is not random: a dormitory behaves like a small population with its own R0, much higher than the national average. This is why a country can have high coverage and a campus can still have an outbreak. Estimates of R0 for mumps vary by setting and study, so this article uses the numbers above only to illustrate the arithmetic.

What the immune system does

When mumps virus infects a person for the first time, the body makes antibodies against the HN and F proteins, along with T cells that hunt infected cells. For how antibodies are built, see antibody structure and immune defense. For the sequence of events in a typical viral infection, see how the human immune system fights viruses.

Unlike herpesviruses, which settle into long-term latency (a quiet state inside cells, discussed in the herpes virus guide), mumps is cleared. Natural infection generally leaves strong protection, though reinfections are documented, and the vaccine mimics that without the disease. The difference between the two is that vaccine-induced antibody levels start lower and drift downward.

Common misconceptions

"Mumps is only a childhood disease." In recent outbreaks, young adults in college, schools, and congregate settings have been affected. In the 2006 US outbreak, people aged 18 to 24 had the highest incidence, 3.7 times that of all other age groups combined. [16]

"If outbreaks happen in vaccinated people, the vaccine does not work." Vaccinated people had lower rates of disease in the outbreaks studied. In Iowa, the attack rate with two doses was 14.5 per 1,000, a level that still left most students uninfected. [17] The vaccine reduced disease and severity, but it did not give everyone lifelong protection.

"The virus has mutated to escape the vaccine." The data reviewed by Lewnard and Grad found no evidence that genotypes changed vaccine effectiveness once waning was accounted for. [15]

"Mumps always causes swollen cheeks." Some infections are mild or silent, particularly in vaccinated people, which makes outbreak detection harder. [6]

"Mumps causes sterility." Severe fertility effects are not the usual outcome. Orchitis is serious, but it most often affects one testis, and any concern about fertility should be discussed with a clinician.

What this means

Mumps is a case study in how vaccines and populations interact. The vaccine works well for individuals and has reduced reported US cases by more than 99%, but its protection fades gradually, and the places where people spend long hours together can turn a small drop in immunity into a chain of infections. Outbreaks in vaccinated groups are evidence of waning and close contact, not proof that vaccination failed.

The practical consequences follow from the evidence: keep two-dose coverage high, treat suspected cases promptly because people are contagious before swelling appears, and consider a third dose during an outbreak, which in Iowa was linked to a markedly lower risk than two doses. Whether routine adult boosters would help is an open research question, and the answer will come from trials, not from the model alone.

Frequently asked questions

Q: Can you get mumps if you have been vaccinated? A: Yes, though it is less common and usually milder. England's 2004 to 2005 outbreak gave estimates of 88% effectiveness for one dose and 95% for two. Protection also wanes, and a 2018 model estimated an average of 27 years.

Q: How long are you contagious with mumps? A: The CDC considers people contagious from 2 days before to 5 days after parotid swelling begins. Virus has been found in saliva from 7 days before to 9 days after onset, so shared cups and close contact deserve caution.

Q: Does mumps always cause swollen cheeks? A: No. Infections can be mild or silent, especially in vaccinated people. The CDC notes that most cases and outbreaks now occur among fully vaccinated people in close-contact settings, where milder illness can be missed.

Q: Can mumps orchitis cause infertility? A: Orchitis can shrink the affected testis; 47 of 132 men in one Minnesota series had atrophy afterward. It most often affects one side, so complete loss of fertility is not the usual outcome, but anyone worried should speak with a clinician.

Q: Why do campuses have outbreaks despite high vaccination rates? A: Two factors combine. Protection from the vaccine wanes over years, and dormitories, sports teams, and shared dining create dense contact. In Iowa, 98.1% of students had two doses, and 259 of 20,496 still developed mumps.

Q: What is the third MMR dose used for? A: The Advisory Committee on Immunization Practices recommends it for people at increased risk during an outbreak. In Iowa, a third dose was associated with a 78.1% lower risk than a second dose at 28 days after vaccination.

Q: Is there an antiviral cure for mumps? A: There is no specific antiviral treatment in routine use, so care is supportive. The CDC advises contacting a doctor and limiting contact with others for up to five days after swelling begins.

Sources

1. CDC, "Clinical overview of mumps": https://www.cdc.gov/mumps/hcp/clinical-overview/index.html
2. Rubin SA, et al. (2008). Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak. Journal of Infectious Diseases. https://doi.org/10.1086/590115
3. Kubota et al. (2016). Trisaccharide containing alpha2,3-linked sialic acid is a receptor for mumps virus. PNAS. https://doi.org/10.1073/pnas.1608383113
4. Molecular mechanism of the flexible glycan receptor recognition by mumps virus (2019). Journal of Virology. https://doi.org/10.1128/jvi.00344-19
5. Rubin S, Eckhaus M, Rennick LJ, Bamford CG, Duprex WP (2015). Molecular biology, pathogenesis and pathology of mumps virus. Journal of Pathology 235(2):242-252. https://doi.org/10.1002/path.4445
6. CDC, "Clinical overview of mumps" (incubation, contagious period, vaccination recommendations): https://www.cdc.gov/mumps/hcp/clinical-overview/index.html
7. CDC, "About mumps": https://www.cdc.gov/mumps/about/index.html
8. Yung et al. (2011). Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerging Infectious Diseases. https://doi.org/10.3201/eid1704.101461
9. Barskey AE, et al. (2012). Mumps outbreak in Orthodox Jewish communities in the United States. New England Journal of Medicine 367(18):1704-1713. https://doi.org/10.1056/NEJMoa1202865
10. Zamir CS, et al. (2015). Characteristics of a large mumps outbreak: clinical severity, complications and association with vaccination status. Human Vaccines & Immunotherapeutics. https://doi.org/10.1080/21645515.2015.1021522
11. The incidence and outcome of mumps orchitis in Rochester, Minnesota, 1935 to 1974 (1977). Mayo Clinic Proceedings. (Abstract record via Europe PMC.)
12. Cohen C, et al. (2007). Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerging Infectious Diseases. https://doi.org/10.3201/eid1301.060649
13. Marin M, et al. (2008). Mumps vaccine effectiveness estimates. Vaccine. https://doi.org/10.1016/j.vaccine.2008.04.075
14. Deeks et al. (2011). An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ. https://doi.org/10.1503/cmaj.101371
15. Lewnard JA, Grad YH (2018). Vaccine waning and mumps re-emergence in the United States. Science Translational Medicine 10(433). https://doi.org/10.1126/scitranslmed.aao5945
16. Dayan GH, et al. (2008). Recent resurgence of mumps in the United States. New England Journal of Medicine 358(15):1580-1589. https://doi.org/10.1056/NEJMoa0706589
17. Cardemil CV, et al. (2017). Effectiveness of a third dose of MMR vaccine for mumps outbreak control. New England Journal of Medicine 377(10):947-956. https://doi.org/10.1056/NEJMoa1703309

---

Read next:

• Rubella Virus Explained: German Measles & CRS
• Adenovirus Explained: The Hardy Virus Behind Many Diseases
• Cytomegalovirus (CMV): A Complete Deep Dive